Related Experiment Video

Updated: Aug 17, 2026

Assay Development for High-Throughput Drug Screening Against Mycobacteria
07:50

Assay Development for High-Throughput Drug Screening Against Mycobacteria

Published on: October 25, 2024

Oritavancin: a new avenue for resistant Gram-positive bacteria

Renee-Claude Mercier1, Lenka Hrebickova

  • 1University of New Mexico, College of Pharmacy, MSC09 5360, 1 University of New Mexico, Albuquerque, NM 87131-0001, USA. rmercier@unm.edu

Expert Review of Anti-Infective Therapy
|June 16, 2005
PubMed

Insights

Oritavancin shows potent activity against resistant bacteria, including vancomycin-resistant strains. This new glycopeptide demonstrated efficacy in skin infections and has a favorable safety profile, offering a promising treatment option.

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Microbiology

Background:

  • Emergence of antibiotic resistance poses a significant global health threat.
  • Vancomycin remains a critical antibiotic but faces challenges with resistant strains.
  • Novel therapeutic agents are needed to combat multidrug-resistant Gram-positive bacteria.

Purpose of the Study:

  • To evaluate the efficacy and safety of oritavancin.
  • To assess oritavancin's activity against resistant bacterial pathogens.
  • To determine oritavancin's potential in treating complicated skin and skin structure infections.

Main Methods:

  • Clinical trials were conducted to assess oritavancin's efficacy.
  • Comparative analysis with standard treatment regimens (vancomycin/cephalexin).
  • Pharmacokinetic profiling including half-life and protein binding.

Main Results:

  • Oritavancin demonstrated potent antimicrobial activity, including against vancomycin-resistant staphylococci and enterococci.
  • The drug exhibited a long terminal half-life (360 h) and high protein binding.
  • Non-inferiority was observed when compared to vancomycin/cephalexin in complicated skin and skin structure infections.
  • A favorable side-effect profile was noted.

Conclusions:

  • Oritavancin is a promising new semisynthetic glycopeptide.
  • It offers an effective treatment option for multidrug-resistant Gram-positive bacterial infections.
  • Its pharmacokinetic properties and safety profile support its clinical utility.

More Related Videos

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

Characterizing Multidrug Efflux Systems in Acinetobacter baumannii Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System05:06

Characterizing Multidrug Efflux Systems in Acinetobacter baumannii Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System

Published on: January 5, 2024

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Antibiotic Selection00:57

Antibiotic Selection

Overview
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...